{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:49:25Z","timestamp":1788958165746,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.micinf.2023.105100","type":"journal-article","created":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T17:09:13Z","timestamp":1674407353000},"page":"105100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Ushasi","family":"Bhaumik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prolay","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3170-9851","authenticated-orcid":false,"given":"Debaki Ranjan","family":"Howlader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumalya","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhrid","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemanta","family":"Koley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2023.105100_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2023.105100_bib2","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.1016\/j.vaccine.2017.07.036","article-title":"Global burden of diarrheal diseases among children in developing countries: incidence, etiology, and insights from new molecular diagnostic techniques","volume":"35","author":"Kotloff","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2023.105100_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.2009.80.609","article-title":"Global etiology of travelers' diarrhea: systematic review from 1973 to the present","volume":"80","author":"Shah","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.micinf.2023.105100_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CMR.00032-07","article-title":"Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion","volume":"21","author":"Schroeder","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.micinf.2023.105100_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jiph.2017.09.025","article-title":"Emergence of antibiotic resistant Shigella species: a matter of concern","volume":"11","author":"Puzari","year":"2018","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.micinf.2023.105100_bib6","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development for Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2023.105100_bib7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"Van der Pol","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.micinf.2023.105100_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.micinf.2023.105100_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membrane vesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2023.105100_bib10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/hv.24129","article-title":"Vaccines against meningococcal serogroup B disease containing outer mem- brane vesicles (OMV): lessons from past programs and implications for the future","volume":"9","author":"Holst","year":"2013","journal-title":"Hum Vaccin Immun- other"},{"key":"10.1016\/j.micinf.2023.105100_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei vaccine based on generalized Modules for membrane antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2023.105100_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1574-695X.2012.01004.x","article-title":"Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice","volume":"66","author":"Mitra","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.micinf.2023.105100_bib13","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.vaccine.2013.05.001","article-title":"Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis","volume":"3","author":"Mitra","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2023.105100_bib14","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.micinf.2023.105100_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cid\/ciu468","article-title":"Shigella isolates from the global enteric multicenter study inform vaccine development","volume":"59","author":"Livio","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.micinf.2023.105100_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.vaccine.2020.11.040","article-title":"Bivalent non-typhoidal Salmonella outer membrane vesicles immunized mice sera confer passive protection against gastroenteritis in a suckling mice model","volume":"39","author":"Maiti","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2023.105100_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","article-title":"Colorimetric method for determination of sugars and related substances","volume":"28","author":"DuBois","year":"1956","journal-title":"Anal Chem"},{"key":"10.1016\/j.micinf.2023.105100_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.imbio.2016.03.002","article-title":"Evaluation of immunogenicity and protective efficacy of combination heat-killed immunogens from three entero-invasive bacteria in rabbit model","volume":"221","author":"Mukherjee","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.micinf.2023.105100_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203631","article-title":"Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever","volume":"13","author":"Howlader","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2023.105100_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/iai.24.2.441-448.1979","article-title":"Enzyme-linked immunosorbent assay for immunoglobulin G and immunoglobulin A antibodies to Shigella flexneri antigens","volume":"24","author":"Keren","year":"1979","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.micinf.2023.105100_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/infdis\/jit399","article-title":"A\u00a0mouse model of shigellosis by intraperitoneal infection","volume":"209","author":"Yang","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2023.105100_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/CVI.00683-13","article-title":"Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine","volume":"21","author":"Kaminski","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.micinf.2023.105100_bib23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/1348-0421.12095","article-title":"Protective immunity by oral immunization with heat-killed Shigella strains in a Guinea pig colitis model","volume":"57","author":"Barman","year":"2013","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.micinf.2023.105100_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12967-018-1439-1","article-title":"T\u00a0cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans","volume":"16","author":"Toapanta","year":"2018","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.micinf.2023.105100_bib25","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1128\/IAI.73.12.8027-8032.2005","article-title":"Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers","volume":"73","author":"Orr","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2023.105100_bib26","series-title":"A\u00a0novel live attenuated shigella vaccine","author":"Nagy","year":"2014"},{"key":"10.1016\/j.micinf.2023.105100_bib27","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2007.12.040","article-title":"Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a","volume":"26","author":"Turbyfill","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2023.105100_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12934-015-0195-7","article-title":"In\u00a0vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in\u00a0vivo glycosylation","volume":"14","author":"K\u00e4mpf","year":"2015","journal-title":"Microb Cell Factories"},{"key":"10.1016\/j.micinf.2023.105100_bib29","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1016\/j.vaccine.2013.05.100","article-title":"Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate","volume":"31","author":"Pore","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2023.105100_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715393","article-title":"GMMA-based vaccines: the known and the unknown","volume":"12","author":"Mancini","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2023.105100_bib31","first-page":"101076","article-title":"Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: results from a phase 2b randomized, placebo-controlled challenge study in adults","volume":"39","author":"Frenck","year":"2021","journal-title":"Clin Med"},{"key":"10.1016\/j.micinf.2023.105100_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/clinids\/13.Supplement_4.S279","article-title":"The lipopolysaccharide of Shigella bacteria as a virulence factor","volume":"134","author":"Lindberg","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.micinf.2023.105100_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/iai.53.1.110-115.1986","article-title":"Shigella flexneri O-antigen epitopes: chemical and immunochemical analyses reveal that epitopes of type III and group 6 antigens are identical","volume":"53","author":"Carlin","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2023.105100_bib34","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1128\/iai.55.6.1412-1420.1987","article-title":"Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains","volume":"55","author":"Carlin","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2023.105100_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1099\/mic.0.2006\/001107-0","article-title":"Structural and genetic evidence that the Escherichia coli O148 O antigen is the precursor of the Shigella dysenteriae type 1 O antigen and identification of a glucosyltransferase gene","volume":"153","author":"Feng","year":"2007","journal-title":"Microbiology"},{"key":"10.1016\/j.micinf.2023.105100_bib36","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/IAI.06174-11","article-title":"Broadly protective Shigella vaccine based on type III secretion apparatus proteins","volume":"80","author":"Martinez-Becerra","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2023.105100_bib37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/clinids\/15.2.346","article-title":"Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae\u00a0and\u00a0shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides","volume":"15","author":"Robbins","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.micinf.2023.105100_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1479-5876-10-4","article-title":"Effects of adjuvants on IgG subclasses elicited by virus-like particles","volume":"10","author":"Visciano","year":"2012","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.micinf.2023.105100_bib39","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.4049\/jimmunol.0901838","article-title":"Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits","volume":"183","author":"Boullier","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2023.105100_bib40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0264-410X(96)00006-0","article-title":"Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection","volume":"14","author":"Van De Verg","year":"1996","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.micinf.2023.105100_bib41","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.vaccine.2015.07.019","article-title":"Serum bactericidal antibody assays - the role of complement in infection and immunity","volume":"33","author":"McIntosh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2023.105100_bib42","doi-asserted-by":"crossref","first-page":"671325","DOI":"10.3389\/fimmu.2021.671325","article-title":"Antibodies elicited by the Shigella sonnei GMMA vaccine in adults trigger complement-mediated serum bactericidal activity: results from a phase 1 dose escalation trial followed by a booster extension","volume":"12","author":"Micoli","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2023.105100_bib43","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1128\/iai.63.5.1947-1954.1995","article-title":"Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection","volume":"63","author":"Van de Verg","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2023.105100_bib44","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1128\/IAI.66.4.1342-1348.1998","article-title":"An essential role for gamma interferon in innate resistance to Shigella flexneri infection","volume":"66","author":"Way","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2023.105100_bib45","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2023.105100_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T\u00a0cell responses: naive to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.micinf.2023.105100_bib47","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.4049\/jimmunol.0900978","article-title":"Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity","volume":"184","author":"Sellge","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2023.105100_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harbor Perspect Biol"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457923000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457923000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:41:22Z","timestamp":1761144082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457923000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1286457923000035"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2023.105100","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2023.105100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105100"}}